Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agios Pharmaceuticals Inc (NASDAQ:AGIO)

42.77
Delayed Data
As of Jul 01
 +0.88 / +2.09%
Today’s Change
33.50
Today|||52-Week Range
120.96
-34.12%
Year-to-Date
Agios Pharmaceuticals (AGIO) Is Today's Dead Cat Bounce Stock
Jul 01 / TheStreet.com - Paid Partner Content
3 Biotech Stocks to Buy Now for the Long Haul
Jun 25 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close41.90
Today’s open41.65
Day’s range40.51 - 43.47
Volume735,197
Average volume (3 months)799,334
Market cap$1.6B
Dividend yield--
Data as of 4:00pm ET, 07/01/2016

Growth & Valuation

Earnings growth (last year)-98.11%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-9.55%
P/E ratioNM
Price/Sales41.10
Price/Book4.58

Competitors

 Today’s
change
Today’s
% change
EXAMExamWorks Group Inc+0.04+0.11%
NEONeogenomics Inc+0.04+0.50%
GNMKGenMark Diagnostics ...+0.35+4.02%
RDNTRadNet Inc+0.05+0.94%
Data as of 4:02pm ET, 07/01/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$1.30
Annual revenue (last year)$59.1M
Annual profit (last year)-$117.7M
Net profit margin-199.14%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David Paul Schenkein
Senior Vice President-Finance &
Contact Person
Glenn Goddard
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs